Lv64
2750 积分 2022-05-31 加入
Update on B‐cell maturation antigen‐directed therapies in AL amyloidosis
6天前
已完结
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial
14天前
已完结
Efficacy and safety of stapokibart in adolescents with moderate-to-severe atopic dermatitis: a multicentre randomized double-blind placebo-controlled phase III trial
14天前
已完结
Global, regional, and national burden of asthma and atopic dermatitis, 1990–2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
14天前
已完结
Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
16天前
已完结
Efficacy and safety of ruxolitinib cream for the treatment of moderate to severe chronic hand eczema: Results from a 16-week, multicenter, randomized, double-blind study
16天前
已完结
Ivarmacitinib for the treatment of adults with severe alopecia areata: Results from a phase 3 trial
16天前
已完结
Evaluation of dupilumab dosing regimen in patients with persistently controlled atopic dermatitis
1个月前
已完结
Use of Extended Dosing Intervals of Dupilumab in Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
1个月前
已完结
Use of Extended Dosing Intervals of Dupilumab in Treatment of Atopic Dermatitis: A Systematic Review and Meta-Analysis
1个月前
已关闭
皖公网安备34019202002308
